Geode Capital Management, LLC Eloxx Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

  • $1.12 Trillion
  • Q2 2024

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.15 - $7.2 $789 - $37,908
5,265 Added 0.66%
807,678 $137,000
Q2 2022

Aug 12, 2022
BUY
$0.24 - $0.58 $499 - $1,206
2,080 Added 0.26%
802,413 $214,000
Q1 2022

May 13, 2022
BUY
$0.4 - $0.72 $910 - $1,638
2,275 Added 0.29%
800,333 $448,000
Q4 2021

Feb 11, 2022
BUY
$0.62 - $1.61 $15,637 - $40,607
25,222 Added 3.26%
798,058 $558,000
Q3 2021

Nov 12, 2021
BUY
$1.22 - $2.0 $299,545 - $491,058
245,529 Added 46.56%
772,836 $1.26 Million
Q2 2021

Aug 13, 2021
BUY
$1.35 - $3.36 $112,720 - $280,549
83,497 Added 18.81%
527,307 $1.05 Million
Q1 2021

May 12, 2021
BUY
$3.02 - $4.54 $72,676 - $109,255
24,065 Added 5.73%
443,810 $1.47 Million
Q4 2020

Feb 12, 2021
BUY
$2.42 - $4.48 $7,855 - $14,542
3,246 Added 0.78%
419,745 $1.67 Million
Q3 2020

Nov 13, 2020
BUY
$2.53 - $3.4 $49,350 - $66,320
19,506 Added 4.91%
416,499 $1.1 Million
Q2 2020

Aug 13, 2020
BUY
$1.56 - $3.65 $18,301 - $42,821
11,732 Added 3.05%
396,993 $1.2 Million
Q1 2020

May 14, 2020
BUY
$1.96 - $7.96 $76,653 - $311,307
39,109 Added 11.3%
385,261 $755,000
Q4 2019

Feb 13, 2020
BUY
$3.19 - $7.56 $168,355 - $398,986
52,776 Added 17.99%
346,152 $2.55 Million
Q3 2019

Nov 12, 2019
BUY
$4.37 - $9.91 $96,480 - $218,792
22,078 Added 8.14%
293,376 $1.33 Million
Q2 2019

Aug 14, 2019
BUY
$8.77 - $12.49 $217,303 - $309,477
24,778 Added 10.05%
271,298 $2.7 Million
Q1 2019

May 14, 2019
BUY
$10.45 - $13.94 $89,180 - $118,963
8,534 Added 3.59%
246,520 $2.88 Million
Q4 2018

Feb 13, 2019
BUY
$10.43 - $17.39 $225,642 - $376,215
21,634 Added 10.0%
237,986 $2.86 Million
Q3 2018

Nov 13, 2018
BUY
$11.95 - $19.63 $163,141 - $267,988
13,652 Added 6.74%
216,352 $3.69 Million
Q2 2018

Aug 14, 2018
BUY
$8.75 - $23.27 $1.77 Million - $4.72 Million
202,700 New
202,700 $3.46 Million

About Eloxx Pharmaceuticals, Inc.

ELOX Quotes by TradingView
  • Ticker ELOX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,656,200
  • Description
  • Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...
More about ELOX
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email